Skip to main content

Table 1 Clinical characteristics of 53 consecutive patients treated with CRS and HIPEC between February 2010 and March 2016 at our institution

From: Pressurized intraperitoneal aerosol chemotherapy (PIPAC) as a neoadjuvant therapy before cytoreductive surgery and hyperthermic intraperitoneal chemotherapy

Patients

All

Primary CRS and HIPEC

Secondary CRS and HIPEC (after PIPAC)

Number of patients

53

32

21

Age (years)

55.8 ± 9.5

55.3 ± 9.6

56.3 ± 9.5

Sex (M:F)

20:33

8:24

12:9

Karnofsky index (%)

86.0 ± 10.1

85.9 ± 11.0

92.1 ± 5.6

Organ

 -Ovarian

15 (28 %)

11 (35 %)

4 (19 %)

 -Colorectal/appendix

19 (36 %)

8 (25 %)

11 (52 %)

 -PMP

9 (17 %)

7 (22 %)

2 (10 %)

 -Gastric

6 (11 %)

3 (9 %)

3 (14 %)

 -Mesothelioma

4 (8 %)

3 (9 %)

1 (5 %)

Peritoneal Carcinomatosis index (initial PCI)

12 ± 8

13.3 ± 9.0

11.5 ± 6.4

Ascites (ml)

147 ± 466

0 ± 0

198 ± 536